TABLE 2

Antibiotics, Laboratory Testing, and Clinical Care Outcomes in Well-Appearing CE Infants

Pre-QIaPhase IPhase II
n = 277n = 319
Antibiotics, n (%)All (100)32 (11.6)15 (4.7)
Sepsis laboratory testing, n (%)All (100)48 (17.3)23 (7.2)
Couplet care throughout hospitalization, n (%)0 (0)0 (0)295 (92.5)b
Exclusive breastfeeding at discharge, n (%)131 (47.3)161 (50.5)
  • —, not applicable.

  • a Represents historical institutional standard of care, which included empirical antibiotics, sepsis laboratory testing, and admission to level II NICU for any infant who was CE.

  • b P < .001 versus phase I.